Viewing Study NCT00648960


Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2026-01-05 @ 12:36 PM
Study NCT ID: NCT00648960
Status: COMPLETED
Last Update Posted: 2008-04-01
First Post: 2008-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State
Sponsor: Mylan Pharmaceuticals Inc
Organization:

Organization Data

Organization:
Class: UNKNOWN
Study ID: CAI-P3-134
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Elliot Offman Director, Biopharmaceutics
Old Organization: Genpharm ULC

Collaborators

Collaborators

Name Class View
None INDUSTRY View